Advertisement

Topics

I-Therapeutix, Inc. Company Profile

04:10 EDT 23rd September 2018 | BioPortfolio


News Articles [26 Associated News Articles listed on BioPortfolio]

Quotidian Technical Highlights on Selected Biotech Stocks -- Ocular Therapeutix, Onconova ...

www.wallstequities.com/registration Ocular Therapeutix On Monday, shares in Bedford, Massachusettsheadquartered Ocular Therapeutix Inc. recorded a trading volume of 158,186 shares. The stock ended...

Ocular Therapeutix Announces NDA Resubmission of DEXTENZA

Ocular Therapeutix (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announc...

Ocular Therapeutix To Present at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco on April 8-10, 2018

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, ...

Ocular Therapeutix files third NDA for ocular pain drug

A new drug application was filed for the third time by Ocular Therapeutix for Dextenza, or dexamethasone insert, 0.4 mg to tr -More- 

Ocular Therapeutix resubmits NDA for DEXTENZA

Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced th...

Ocular Therapeutix™ to Present at the 2018 JMP Securities Life Sciences Conference

Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development and commercialization of innovative therapies for diseases and condition...

Ocular Therapeutix: Elucidating The Upcoming Regulatory Binary

Ocular Therapeutix™ to Present at the H.C. Wainwright 20th Annual Global Investment Conference

Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditio...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Ocular Therapeutix, Inc. 

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of t...

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. is a privately held company based in Bedford, MA, focused on the development and commercialization of ophthalmic therapeutic products using its proprietar...

Ora, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its p...

Ocular Therapeutix™, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the ...

I-Therapeutix, Inc.

More Information about "I-Therapeutix, Inc." on BioPortfolio

We have published hundreds of I-Therapeutix, Inc. news stories on BioPortfolio along with dozens of I-Therapeutix, Inc. Clinical Trials and PubMed Articles about I-Therapeutix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of I-Therapeutix, Inc. Companies in our database. You can also find out about relevant I-Therapeutix, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record